Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection

Probiotics given before or after standard triple therapy significantly improve H. pylori eradication rates with minimal side effects. A multicenter randomized trial involving 234 H. pylori–positive gastritis patients investigated whether adding probiotics could improve eradication rates of standard triple therapy. Per-protocol analysis showed eradication rates of 81.6% and 82.4%. Symptom relief rates were comparable across groups, and adverse effects were rare.